Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05764213 · ClinicalTrials.gov registry record · NA

Improving Maternal Mental Health & SUD Screening and Treatment

A NA study of Substance Use Disorders and Mental Health Issue, sponsored by Medical University of South Carolina.

Active
Registry status
NA
Development phase
10,473
Enrollment target
1
Study location

NCT05764213: Active NA study of Substance Use Disorders and Mental Health Issue, sponsored by Medical University of South Carolina.

NCT05764213 is a NA study of Substance Use Disorders and Mental Health Issue that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 10,473 participants, above the 387-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (2606% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05764213, a NA study of Substance Use Disorders and Mental Health Issue, is active but no longer recruiting, sponsored by Medical University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10,473 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to compare a text message-based mental health and substance use screening and referral to a treatment program, called Listening to Women and Pregnant and Postpartum People (LTWP), to standard of care in-person mental health and substance use screening to look at rates of treatment attendance and retention in treatment. Participation would involve completing online questionnaires. You may be eligible to participate if you are age 18-45 years, are pregnant and entering prenatal care in one of MUSC's OB clinics, and attended a prenatal appointment at an MUSC clinic.

Primary Outcome

Treatment attendance is defined as attending at least 1 or more visits with a mental health or substance use disorder treatment provider.

Interventions

  • BEHAVIORAL Listening to Women & Pregnant and Postpartum People

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 10,473 participants
Start Date 2023-04-03
Est. Completion 2027-10-01
Phase NA

What the registry record for NCT05764213 still lists

NCT05764213 is an interventional study that assigns participants to a tested intervention. Its 10,473 participants enrollment target places it among the larger protocols in the corpus, above the 387-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (2606% higher).

The record links to 4 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Listening to Women & Pregnant and Postpartum People is the first listed.

NCT05764213 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT05764213 about?

NCT05764213 is a clinical study titled "Improving Maternal Mental Health & SUD Screening and Treatment". The purpose of the study is to compare a text message-based mental health and substance use screening and referral to a treatment program, called Listening to Women and Pregnant and Postpartum People (LTWP), to standard of care in-person mental health and substance use screening to look at rates of ...

What is the current status of trial NCT05764213?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10,473 participants. The study started on 2023-04-03. Estimated completion is 2027-10-01.

What conditions does trial NCT05764213 study?

This clinical trial studies the following conditions: Substance Use Disorders, Mental Health Issue, Postpartum Depression, Postpartum Anxiety.

What interventions are being tested in trial NCT05764213?

The interventions under investigation include: Listening to Women & Pregnant and Postpartum People (BEHAVIORAL).

Who is sponsoring clinical trial NCT05764213?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05764213 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05764213's enrollment target sits among peer trials

10,473 2nd of 93 the highest of 93 other Substance Use Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07157774 · 10,450 participants · Phase 3

    Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • NCT05759299 · 10,500 participants

    International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

  • NCT06891222 · 10,500 participants

    A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

  • NCT06081517 · 10,600 participants

    Evaluating Disparities in Precision Oncology

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05764213, the US trial registry maintained by the National Library of Medicine. NCT05764213 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.